A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
AbbVie
Eli Lilly and Company
Shandong Suncadia Medicine Co., Ltd.
Pfizer
Jiangsu HengRui Medicine Co., Ltd.
Indiana University
AstraZeneca
AstraZeneca
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center